Literature DB >> 30689700

The Macrophage 'Do not eat me' signal, CD47, is a clinically validated cancer immunotherapy target.

C H Takimoto1, M P Chao2, C Gibbs2, M A McCamish2, J Liu2, J Y Chen2, R Majeti3, I L Weissman4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30689700     DOI： 10.1093/annonc/mdz006

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  23 in total

1.  Dysregulated integrin αVβ3 and CD47 signaling promotes joint inflammation, cartilage breakdown, and progression of osteoarthritis.

Authors:  Qian Wang; Kazuhiro Onuma; Changhao Liu; Heidi Wong; Michelle S Bloom; Eileen E Elliott; Richard Rl Cao; Nick Hu; Nithya Lingampalli; Orr Sharpe; Xiaoyan Zhao; Dong Hyun Sohn; Christin M Lepus; Jeremy Sokolove; Rong Mao; Cecilia T Cisar; Harini Raghu; Constance R Chu; Nicholas J Giori; Stephen B Willingham; Susan S Prohaska; Zhen Cheng; Irving L Weissman; William H Robinson
Journal:  JCI Insight       Date:  2019-09-19

2.  SurfaceGenie: a web-based application for prioritizing cell-type-specific marker candidates.

Authors:  Matthew Waas; Shana T Snarrenberg; Jack Littrell; Rachel A Jones Lipinski; Polly A Hansen; John A Corbett; Rebekah L Gundry
Journal:  Bioinformatics       Date:  2020-06-01       Impact factor: 6.937

Review 3.  Beyond direct killing-novel cellular immunotherapeutic strategies to reshape the tumor microenvironment.

Authors:  Duc Huynh; Pia Winter; Florian Märkl; Stefan Endres; Sebastian Kobold
Journal:  Semin Immunopathol       Date:  2022-09-27       Impact factor: 11.759

4.  Metabolic Reprogramming of Mouse Bone Marrow Derived Macrophages Following Erythrophagocytosis.

Authors:  Alexis Catala; Lyla A Youssef; Julie A Reisz; Monika Dzieciatkowska; Nicholas E Powers; Carlo Marchetti; Matthew Karafin; James C Zimring; Krystalyn E Hudson; Kirk C Hansen; Steven L Spitalnik; Angelo D'Alessandro
Journal:  Front Physiol       Date:  2020-04-30       Impact factor: 4.566

5.  Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition.

Authors:  Michal Caspi Tal; Laughing Bear Torrez Dulgeroff; Lara Myers; Irving L Weissman; Kim J Hasenkrug; Lamin B Cham; Katrin D Mayer-Barber; Andrea C Bohrer; Ehydel Castro; Ying Ying Yiu; Cesar Lopez Angel; Ed Pham; Aaron B Carmody; Ronald J Messer; Eric Gars; Jens Kortmann; Maxim Markovic; Michaela Hasenkrug; Karin E Peterson; Clayton W Winkler; Tyson A Woods; Paige Hansen; Sarah Galloway; Dhananjay Wagh; Benjamin J Fram; Thai Nguyen; Daniel Corey; Raja Sab Kalluru; Niaz Banaei; Jayakumar Rajadas; Denise M Monack; Aijaz Ahmed; Debashis Sahoo; Mark M Davis; Jeffrey S Glenn; Tom Adomati; Karl S Lang
Journal:  mBio       Date:  2020-06-23       Impact factor: 7.867

6.  CD47 Overexpression Is Associated with Epstein-Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma.

Authors:  Zhi-Hui Wang; Xiao-Feng Pei; Zhi-Quan Zhu; Zhong Lin; Yin-Yan Mao; Xiao-Lu Xu; You-Li Luo; Li Zhang; Pei-Jian Peng
Journal:  Onco Targets Ther       Date:  2020-04-21       Impact factor: 4.147

Review 7.  The Ban on US Government Funding Research Using Human Fetal Tissues: How Does This Fit with the NIH Mission to Advance Medical Science for the Benefit of the Citizenry?

Authors:  Joseph M McCune; Irving L Weissman
Journal:  Stem Cell Reports       Date:  2019-11-12       Impact factor: 7.765

Review 8.  Ocoxin as a complement to first line treatments in cancer.

Authors:  Aitor Benedicto; Eduardo Sanz; Joana Márquez
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

9.  Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer.

Authors:  Yan Xu; Ji Li; Bing Tong; Minjiang Chen; Xiaoyan Liu; Wei Zhong; Jing Zhao; Mengzhao Wang
Journal:  ESMO Open       Date:  2020-08

10.  Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell 'don't eat me' signals off and 'eat me' signals on.

Authors:  Suchismita Mohanty; Maryam Aghighi; Ketan Yerneni; Johanna Lena Theruvath; Heike E Daldrup-Link
Journal:  Mol Oncol       Date:  2019-08-13       Impact factor: 6.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.